跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 622 条关于
“Crigler Najjar”
全部
622
临床试验
593
药物
2
机构
5
资讯
22
去年
Imlifidase Shows Promise in Guillain-Barré Syndrome and Expands Gene Therapy Access
去年
Hansa Biopharma's Imlifidase Shows Promise in Guillain-Barré Syndrome and Anti-GBM Disease
去年
Genethon's GNT0004 Gene Therapy Shows Promise in Duchenne Muscular Dystrophy Trial
去年
Hansa Biopharma Secures $24.3M Funding as IDEFIRIX Sales Surge 76% in Q2 2025
5个月前
AAV Gene Therapy Pipeline Surpasses 250 Candidates as FDA Approvals and Late-Stage Trials Accelerate in 2026
2个月前
Point-of-Care CAR-T Manufacturing Achieves 15-Day Vein-to-Vein Time in Jordan Phase II Trial
2个月前
Smart Nanoplatform Uses Wound Acidity to Trigger Accelerated Healing
10个月前
Recursion Pharmaceuticals Names Najat Khan as New CEO in Leadership Transition
9个月前
Kinase Inhibitors Discovered to Trigger Widespread Protein Degradation Beyond Traditional Inhibition
去年
CB1 Agonist Trial Results Trigger Stock Drop for Corbus and Novo Nordisk
第 1 页,共 3 页
上一页
下一页